DAVA INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Endava plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO, Aug. 31, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Endava plc (NYSE: DAVA) securities between May 23, 2023 and February 28, 2024, both dates inclusive (the “Class Period”), have until October 25, 2024 to seek appointment as lead plaintiff of the Endava class action lawsuit. Captioned Mueller v. Endava, plc, No. 24-cv-06423 (S.D.N.Y.), the Endava class action lawsuit charges Endava and certain of Endava’s top executives with violations of the Securities Exchange Act of 1934.
If you suffered substantial losses and wish to serve as lead plaintiff of the Endava class action lawsuit, please provide your information here:
https://www.rgrdlaw.com/cases-endava-plc-class-action-lawsuit-dava.html
You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at info@rgrdlaw.com.
CASE ALLEGATIONS: Endava provides technology services for clients in consumer products, healthcare, mobility, and retail verticals.
The Endava class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) demand for Endava’s services was declining; (ii) Endava’s clients delayed or cancelled projects; and (iii) as a result, Endava’s fiscal 2023 and 2024 revenue and earnings would be adversely affected.
The Endava class action lawsuit further alleges that on February 29, 2024, Endava reported its financial results for the second quarter 2024, revealing quarterly revenue of £183.6 million, a decrease of 10.6% compared to the same period in the prior year, and full fiscal year 2024 expected revenue in the range of £722.0 million to £735.0 million. On this news, the price of Endava American Depositary Shares fell nearly 42%, according to the complaint.
THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Endava securities during the Class Period to seek appointment as lead plaintiff in the Endava class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Endava class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Endava class action lawsuit. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Endava class action lawsuit.
ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud cases. Our Firm has been #1 in the ISS Securities Class Action Services rankings for six out of the last ten years for securing the most monetary relief for investors. We recovered $6.6 billion for investors in securities-related class action cases – over $2.2 billion more than any other law firm in the last four years. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest securities class action recovery ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:
https://www.rgrdlaw.com/services-litigation-securities-fraud.html
Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Contact:
Robbins Geller Rudman & Dowd LLP
J.C. Sanchez, Jennifer N. Caringal
655 W. Broadway, Suite 1900, San Diego, CA 92101
800-449-4900
info@rgrdlaw.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.